blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3103803

EP3103803 - INTERMEDIATES FOR THE SYNTHESIS OF MTOR KINASE INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  15.01.2021
Database last updated on 13.07.2024
FormerThe patent has been granted
Status updated on  07.02.2020
FormerGrant of patent is intended
Status updated on  01.10.2019
FormerExamination is in progress
Status updated on  06.10.2017
FormerRequest for examination was made
Status updated on  16.06.2017
FormerThe application has been published
Status updated on  11.11.2016
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Signal Pharmaceuticals, LLC
10300 Campus Point Drive
Suite 100
San Diego, CA 92121 / US
[2016/50]
Inventor(s)01 / PERRIN-NINKOVIC, Sophie
8902 Nottingham Place
La Jolla CA 92037 / US
02 / HARRIS, Roy L.
1075 Chalcedony St., Apt. A
San Diego CA 92109 / US
03 / SAPIENZA, John
1654 Ridge Rock Ct.
Chula Vista CA 91913 / US
04 / SHEVLIN, Graziella I.
Jirón Trujillo 578
Magdalena del Mar Lima / PE
05 / PAPA, Patrick
5320 Forecastle Ct.
Carlsbad CA 92008 / US
06 / LEE, Branden
11363 Stable Glen Pl.
San Diego CA 92130 / US
07 / PACKARD, Garrick
4741 Grand Ave. S Apt. 1
Minneapolis MN 55419 / US
08 / ZHAO, Jingjing
8323 Bryn Glen Way
San Diego, CA 92129 / US
09 / RIGGS, Jennifer
2136 Wales Drive
Cardiff, CA 92007 / US
10 / PARNES, Jason
10839 Vereda Sol Del Dios
San Diego, CA 92130 / US
11 / MORTENSEN, Deborah
4302 Lodi Court
San Diego, CA 92117 / US
12 / ELSNER, Jan
640 W. Solana Circle, no.3
Solana Beach, CA 92075 / US
 [2020/11]
Former [2017/49]01 / PERRIN-NINKOVIC, Sophie
8902 Nottingham Place
La Jolla CA 92037 / US
02 / HARRIS, Roy L.
1075 Chalcedony St., Apt. A
San Diego CA 92109 / US
03 / SAPIENZA, John
1654 Ridge Rock Ct.
Chula Vista CA 91913 / US
04 / SHEVLIN, Graziella I.
Jirón Trujilla 578
Magdalena del Mar Lima / PE
05 / PAPA, Patrick
5320 Forecastle Ct.
Carlsbad CA 92008 / US
06 / LEE, Branden
11363 Stable Glen Pl.
San Diego CA 92130 / US
07 / PACKARD, Garrick
4741 Grand Ave. S Apt. 1
Minneapolis MN 55419 / US
08 / ZHAO, Jingjing
8323 Bryn Glen Way
San Diego, CA 92129 / US
09 / RIGGS, Jennifer
2136 Wales Drive
Cardiff, CA 92007 / US
10 / PARNES, Jason
10839 Vereda Sol Del Dios
San Diego, CA 92130 / US
11 / MORTENSEN, Deborah
4302 Lodi Court
San Diego, CA 92117 / US
12 / ELSNER, Jan
640 W. Solana Circle, no.3
Solana Beach, CA 92075 / US
Former [2017/41]01 / PERRIN-NINKOVIC, Sophie
8902 Nottingham Place
La Jolla CA 92037 / US
02 / HARRIS, Roy L.
1075 Chalcedony St., Apt. A
San Diego CA 92109 / US
03 / SAPIENZA, John
1654 Ridge Rock Ct.
Chula Vista CA 91913 / US
04 / SHEVLIN, Graziella I.
Jirón Trujilla 578
Magdalena del Mar Lima / PE
05 / PAPA, Patrick
5320 Forecastle Ct.
Carlsbad CA 92008 / US
06 / LEE, Branden
11363 Stable Glen Pl.
San Diego CA 92130 / US
07 / PACKARD, Garrick
4741 Grand Ave. S Apt. 1
Minneapolis MN 55419 / US
08 / ZHAO, Jingjing
8323 Bryn Glen Way
San Diego, CA 92129 / US
09 / RIGGS, Jennifer
2136 Wales Drive
Cardiff, CA 92007 / US
10 / PARNES, Jason
10839 Vereda Sol Del Dios
San Diego, CA 92130 / US
11 / MORTENSEN, Deborah
4302 Lodi Court
San Diego, CA 92117 / US
12 / ELSNER, Jan
640 W. Solana Circle, no.3
Solana Beach, CA 92122 / US
Former [2017/28]01 / PERRIN-NINKOVIC, Sophie
8902 Nottingham Place
La Jolla CA 92037 / US
02 / HARRIS, Roy L.
1075 Chalcedony St., Apt. A
San Diego CA 92109 / US
03 / SAPIENZA, John
1654 Ridge Rock Ct.
Chula Vista CA 91913 / US
04 / SHEVLIN, Graziella I.
Jirón Trujilla 578
Magdalena del Mar Lima / PE
05 / PAPA, Patrick
5320 Forecastle Ct.
Carlsbad CA 92008 / US
06 / LEE, Branden
11363 Stable Glen Pl.
San Diego CA 92130 / US
07 / PACKARD, Garrick
4741 Grand Ave. S Apt. 1
Minneapolis MN 55419 / US
08 / ZHAO, Jingjing
8323 Bryn Glen Way
San Diego, CA 92129 / US
09 / RIGGS, Jennifer
2136 Wales Drive
Cardiff, CA 92007 / US
10 / PARNES, Jason
10839 Vereda Sol Del Dios
San Diego, CA 92130 / US
11 / MORTENSEN, Deborah
4302 Lodi Court
San Diego, CA 92117 / US
12 / ELSNER, Jan
7564 Charmant Dr. 1828
San Diego, CA 92122 / US
Former [2016/50]01 / PERRIN-NINKOVIC, Sophie
8902 Nottingham Place
La Jolla CA 92037 / US
02 / HARRIS, Roy L.
1075 Chalcedony St., Apt. A
San Diego CA 92109 / US
03 / SAPIENZA, John
1654 Ridge Rock Ct.
Chula Vista CA 91913 / US
04 / SHEVLIN, Graziella I.
Jirón Trujilla 578
Magdalena del Mar Lima / PE
05 / PAPA, Patrick
5320 Forecastle Ct.
Carlsbad CA 92008 / US
06 / LEE, Branden
11363 Stable Glen Pl.
San Diego CA 92130 / US
07 / PACKARD, Garrick
4741 Grand Ave. S Apt. 1
Minneapolis MN 55419 / US
Representative(s)Jones Day
Rechtsanwälte, Attorneys-at-Law, Patentanwälte
Prinzregentenstrasse 11
80538 München / DE
[2016/50]
Application number, filing date16171709.527.10.2009
[2016/50]
Priority number, dateUS20080108627P27.10.2008         Original published format: US 108627 P
[2016/50]
Previously filed application, dateEP2014015816127.10.2009
[2016/50]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3103803
Date:14.12.2016
Language:EN
[2016/50]
Type: B1 Patent specification 
No.:EP3103803
Date:11.03.2020
Language:EN
[2020/11]
Search report(s)(Supplementary) European search report - dispatched on:EP15.09.2016
ClassificationIPC:C07D487/04, C07F5/05, C07F7/22
[2019/42]
CPC:
C07D487/04 (EP,CN,KR,RU,US); A61K31/4985 (KR,RU); A61P1/00 (EP);
A61P1/04 (EP); A61P1/16 (EP); A61P1/18 (EP);
A61P11/00 (EP); A61P11/02 (EP); A61P11/06 (EP);
A61P13/12 (EP); A61P17/02 (EP); A61P17/06 (EP);
A61P19/02 (EP); A61P19/06 (EP); A61P21/04 (EP);
A61P25/00 (EP); A61P25/08 (EP); A61P25/14 (EP);
A61P25/16 (EP); A61P25/28 (EP,RU); A61P29/00 (EP,RU);
A61P3/00 (EP); A61P3/04 (EP); A61P3/10 (EP);
A61P35/00 (EP); A61P35/02 (EP); A61P37/00 (EP);
A61P37/02 (EP); A61P37/06 (EP); A61P43/00 (EP);
A61P9/00 (EP,RU); A61P9/10 (EP); C07D241/20 (EP,CN,US);
C07D471/04 (US); C07D471/14 (US); C07D487/10 (US);
C07D487/14 (US); C07D498/14 (KR,US); C07D519/00 (CN);
C07F5/025 (CN) (-)
Former IPC [2016/50]C07D487/04, C07F5/05, C07F7/22, C07D241/20
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2017/29]
Former [2016/50]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
TitleGerman:ZWISCHENPRODUKTE ZUR SYNTHESE VON MTOR-KINASEHEMMER[2016/50]
English:INTERMEDIATES FOR THE SYNTHESIS OF MTOR KINASE INHIBITORS[2016/50]
French:INTERMÉDIAIRES POUR LA SYNTHÈSE D'INHIBITEURS DE KINASE MTOR[2016/50]
Examination procedure27.05.2016Date on which the examining division has become responsible
12.06.2017Amendment by applicant (claims and/or description)
12.06.2017Examination requested  [2017/29]
10.10.2017Despatch of a communication from the examining division (Time limit: M04)
05.02.2018Reply to a communication from the examining division
03.05.2018Despatch of a communication from the examining division (Time limit: M04)
24.07.2018Reply to a communication from the examining division
26.10.2018Despatch of a communication from the examining division (Time limit: M04)
22.02.2019Reply to a communication from the examining division
13.09.2019Cancellation of oral proceeding that was planned for 09.10.2019
02.10.2019Communication of intention to grant the patent
09.10.2019Date of oral proceedings (cancelled)
22.01.2020Fee for grant paid
22.01.2020Fee for publishing/printing paid
22.01.2020Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP09759827.0  / EP2358718
Divisional application(s)EP20152165.5  / EP3660020
Opposition(s)14.12.2020No opposition filed within time limit [2021/07]
Fees paidRenewal fee
27.05.2016Renewal fee patent year 03
27.05.2016Renewal fee patent year 04
27.05.2016Renewal fee patent year 05
27.05.2016Renewal fee patent year 06
27.05.2016Renewal fee patent year 07
11.10.2016Renewal fee patent year 08
27.10.2017Renewal fee patent year 09
29.10.2018Renewal fee patent year 10
28.10.2019Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU27.10.2009
AT11.03.2020
CY11.03.2020
CZ11.03.2020
DK11.03.2020
EE11.03.2020
FI11.03.2020
HR11.03.2020
LT11.03.2020
LV11.03.2020
MC11.03.2020
MK11.03.2020
MT11.03.2020
NL11.03.2020
PL11.03.2020
RO11.03.2020
SE11.03.2020
SI11.03.2020
SK11.03.2020
SM11.03.2020
TR11.03.2020
BG11.06.2020
NO11.06.2020
GR12.06.2020
IS11.07.2020
PT05.08.2020
IE27.10.2020
LU27.10.2020
BE31.10.2020
[2022/32]
Former [2022/27]HU27.10.2009
AT11.03.2020
CY11.03.2020
CZ11.03.2020
DK11.03.2020
EE11.03.2020
FI11.03.2020
HR11.03.2020
LT11.03.2020
LV11.03.2020
MC11.03.2020
MT11.03.2020
NL11.03.2020
PL11.03.2020
RO11.03.2020
SE11.03.2020
SI11.03.2020
SK11.03.2020
SM11.03.2020
TR11.03.2020
BG11.06.2020
NO11.06.2020
GR12.06.2020
IS11.07.2020
PT05.08.2020
IE27.10.2020
LU27.10.2020
BE31.10.2020
Former [2021/46]AT11.03.2020
CZ11.03.2020
DK11.03.2020
EE11.03.2020
FI11.03.2020
HR11.03.2020
LT11.03.2020
LV11.03.2020
MC11.03.2020
NL11.03.2020
PL11.03.2020
RO11.03.2020
SE11.03.2020
SI11.03.2020
SK11.03.2020
SM11.03.2020
BG11.06.2020
NO11.06.2020
GR12.06.2020
IS11.07.2020
PT05.08.2020
IE27.10.2020
LU27.10.2020
BE31.10.2020
Former [2021/36]AT11.03.2020
CZ11.03.2020
DK11.03.2020
EE11.03.2020
FI11.03.2020
HR11.03.2020
LT11.03.2020
LV11.03.2020
MC11.03.2020
NL11.03.2020
PL11.03.2020
RO11.03.2020
SE11.03.2020
SI11.03.2020
SK11.03.2020
SM11.03.2020
BG11.06.2020
NO11.06.2020
GR12.06.2020
IS11.07.2020
PT05.08.2020
LU27.10.2020
BE31.10.2020
Former [2021/31]AT11.03.2020
CZ11.03.2020
DK11.03.2020
EE11.03.2020
FI11.03.2020
HR11.03.2020
LT11.03.2020
LV11.03.2020
MC11.03.2020
NL11.03.2020
PL11.03.2020
RO11.03.2020
SE11.03.2020
SI11.03.2020
SK11.03.2020
SM11.03.2020
BG11.06.2020
NO11.06.2020
GR12.06.2020
IS11.07.2020
PT05.08.2020
LU27.10.2020
Former [2021/11]AT11.03.2020
CZ11.03.2020
DK11.03.2020
EE11.03.2020
FI11.03.2020
HR11.03.2020
LT11.03.2020
LV11.03.2020
NL11.03.2020
PL11.03.2020
RO11.03.2020
SE11.03.2020
SI11.03.2020
SK11.03.2020
SM11.03.2020
BG11.06.2020
NO11.06.2020
GR12.06.2020
IS11.07.2020
PT05.08.2020
Former [2021/08]CZ11.03.2020
DK11.03.2020
EE11.03.2020
FI11.03.2020
HR11.03.2020
LT11.03.2020
LV11.03.2020
NL11.03.2020
RO11.03.2020
SE11.03.2020
SK11.03.2020
SM11.03.2020
BG11.06.2020
NO11.06.2020
GR12.06.2020
IS11.07.2020
PT05.08.2020
Former [2020/50]CZ11.03.2020
EE11.03.2020
FI11.03.2020
HR11.03.2020
LT11.03.2020
LV11.03.2020
NL11.03.2020
RO11.03.2020
SE11.03.2020
SK11.03.2020
SM11.03.2020
BG11.06.2020
NO11.06.2020
GR12.06.2020
IS11.07.2020
PT05.08.2020
Former [2020/49]CZ11.03.2020
FI11.03.2020
HR11.03.2020
LT11.03.2020
LV11.03.2020
NL11.03.2020
RO11.03.2020
SE11.03.2020
SK11.03.2020
SM11.03.2020
BG11.06.2020
NO11.06.2020
GR12.06.2020
IS11.07.2020
PT05.08.2020
Former [2020/48]FI11.03.2020
HR11.03.2020
LT11.03.2020
LV11.03.2020
NL11.03.2020
RO11.03.2020
SE11.03.2020
SM11.03.2020
BG11.06.2020
NO11.06.2020
GR12.06.2020
IS11.07.2020
PT05.08.2020
Former [2020/47]FI11.03.2020
HR11.03.2020
LT11.03.2020
LV11.03.2020
NL11.03.2020
SE11.03.2020
BG11.06.2020
NO11.06.2020
GR12.06.2020
IS11.07.2020
Former [2020/46]FI11.03.2020
HR11.03.2020
LV11.03.2020
NL11.03.2020
SE11.03.2020
BG11.06.2020
NO11.06.2020
GR12.06.2020
IS11.07.2020
Former [2020/45]FI11.03.2020
HR11.03.2020
LV11.03.2020
NL11.03.2020
SE11.03.2020
BG11.06.2020
NO11.06.2020
GR12.06.2020
Former [2020/39]FI11.03.2020
HR11.03.2020
LV11.03.2020
SE11.03.2020
BG11.06.2020
NO11.06.2020
GR12.06.2020
Former [2020/38]FI11.03.2020
HR11.03.2020
LV11.03.2020
SE11.03.2020
NO11.06.2020
GR12.06.2020
Former [2020/37]FI11.03.2020
HR11.03.2020
LV11.03.2020
SE11.03.2020
NO11.06.2020
Former [2020/35]FI11.03.2020
NO11.06.2020
Documents cited:Search[XI]WO2008051493  (SIGNAL PHARM LLC [US], et al);
 [E]WO2011053518  (SIGNAL PHARM LLC [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.